HCP used 'open questions' · Healthcare professionals working with people who have cancer
1 finding from 1 review
Elicited concerns · Healthcare professionals working with people who have cancer
1 finding from 1 review
Gave appropriate information · Healthcare professionals working with people who have cancer
1 finding from 1 review
Empathy · Healthcare professionals working with people who have cancer
1 finding from 1 review
Gave facts only · Healthcare professionals working with people who have cancer
1 finding from 1 review
Emotional exhaustion: Maslach Burnout Inventory: · Healthcare professionals working with people who have cancer
1 finding from 1 review
Anxiety · Healthcare professionals working with people who have cancer
1 finding from 1 review
Maximum number of weeks of consecutive alcohol abstinence during treatment · concurrent problem alcohol and illicit drug users
1 finding from 1 review
Number of participants achieving 3 or more weeks of consecutive alcohol abstinence during treatment · concurrent problem alcohol and illicit drug users
It is very uncertain whether cognitive‐behavioural coping skills training (CBCST) changes number of participants achieving 3 or more weeks of consecutive… compared with twelve‐step facilitation (TSF) programme to reduce alcohol consumption (very low certainty).
1 finding from 1 review
Abstinence from alcohol over the last 30 days · concurrent problem alcohol and illicit drug users
It is very uncertain whether cognitive‐behavioural coping skills training (CBCST) changes alcohol abstinence compared with twelve‐step facilitation (TSF) programme to reduce alcohol consumption (very low certainty).
1 finding from 1 review
Retention [ · concurrent problem alcohol and illicit drug users
It is very uncertain whether cognitive‐behavioural coping skills training (CBCST) changes retention ‐ end of treatment compared with twelve‐step facilitation (TSF) programme to reduce alcohol consumption (very low certainty).
1 finding from 1 review
Intervention not reported
Glatiramer acetate (Direct evidence; 3 RCsT; 1014 participants) · Patients with RRMS Interventions: alemtuzumab, azathriopine, cladribine, dimethylfumarate, fingolimod, glatiramer acetate,…
The intervention probably leads to lower glatiramer acetate (Direct evidence; 3 RCsT; 1014 participants) (moderate certainty).
1 finding from 1 review
RR 0.84 [0.76, 0.93]
3 participants
Moderate